Echocardiographic Markers of Cardiac Response to Therapy in Patients with Light Chain Amyloidosis. [PDF]
Ng D +7 more
europepmc +1 more source
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials. [PDF]
Wechalekar AD +18 more
europepmc +1 more source
Sequential cryoglobulinemia-associated glomerulonephritis and light-chain amyloidosis in monoclonal gammopathy of renal significance. [PDF]
Nakayama Y +4 more
europepmc +1 more source
Hepatic Amyloid Light-Chain Amyloidosis Incidentally Diagnosed via Endoscopic Ultrasound-Guided Liver Biopsy. [PDF]
Tsujiguchi Y +7 more
europepmc +1 more source
A rare coexistence of immunoglobulin light chain amyloidosis and POEMS syndrome manifesting as refractory heart failure: a case report and literature review. [PDF]
Lei M, He H, Yuan M, Liu W.
europepmc +1 more source
Reply: Technetium Pyrophosphate Blood Pool Uptake Mistaken for Myocardial Uptake in Light-Chain Amyloidosis: A Dangerous Misinterpretation. [PDF]
Zambrano Zambrano K +2 more
europepmc +1 more source
Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis. [PDF]
Ye Y +5 more
europepmc +1 more source
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis. [PDF]
Shragai T +7 more
europepmc +1 more source
Outcomes of patients with systemic light chain amyloidosis treated with DVD front-line therapy. [PDF]
Wang J +11 more
europepmc +1 more source
Efficacy of venetoclax in the treatment of relapsed/refractory light-chain amyloidosis. [PDF]
Xiong XY +5 more
europepmc +1 more source

